Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgery versus SABR for resectable non-small-cell lung cancer.
Dearman C, van As N, Crellin A, Slevin N, Sharma RA. Dearman C, et al. Among authors: crellin a. Lancet Oncol. 2015 Aug;16(8):e373-4. doi: 10.1016/S1470-2045(15)00145-X. Lancet Oncol. 2015. PMID: 26248840 No abstract available.
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.
Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, Harper PG, Dunn J, Tudur-Smith C, West J, Falk S, Crellin A, Adab F, Thompson J, Leonard P, Ostrowski J, Eatock M, Scheithauer W, Herrmann R, Neoptolemos JP. Cunningham D, et al. Among authors: crellin a. J Clin Oncol. 2009 Nov 20;27(33):5513-8. doi: 10.1200/JCO.2009.24.2446. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858379 Clinical Trial.
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.
Seymour MT, Thompson LC, Wasan HS, Middleton G, Brewster AE, Shepherd SF, O'Mahony MS, Maughan TS, Parmar M, Langley RE; FOCUS2 Investigators; National Cancer Research Institute Colorectal Cancer Clinical Studies Group. Seymour MT, et al. Lancet. 2011 May 21;377(9779):1749-59. doi: 10.1016/S0140-6736(11)60399-1. Epub 2011 May 11. Lancet. 2011. PMID: 21570111 Free PMC article. Clinical Trial.
Caution is required in the implementation of 90-day mortality indicators for radiotherapy in a curative setting: A retrospective population-based analysis of over 16,000 episodes.
Spencer K, Ellis R, Birch R, Dugdale E, Turner R, Sebag-Montefiore D, Hall G, Crellin A, Morris E. Spencer K, et al. Among authors: crellin a. Radiother Oncol. 2017 Oct;125(1):140-146. doi: 10.1016/j.radonc.2017.07.031. Epub 2017 Aug 23. Radiother Oncol. 2017. PMID: 28844331 Free PMC article.
Proton Beam Therapy - the Challenges of Delivering High-quality Evidence of Clinical Benefit.
National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Proton Beam Clinical Trial Strategy Group. National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Proton Beam Clinical Trial Strategy Group. Clin Oncol (R Coll Radiol). 2018 May;30(5):280-284. doi: 10.1016/j.clon.2018.02.031. Epub 2018 Mar 16. Clin Oncol (R Coll Radiol). 2018. PMID: 29551566
60 results